Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in ChinaHong Zhao, Fuat Kurbanov, Mo-Bin Wan, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive modelMin-De Zeng, Lun-Gen Lu, Yi-Min Mao, et al.
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine|September 2, 2004
[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]Ping Liu, Yi-Yang Hu, Cheng Liu, et al.
World Journal of Gastroenterology|November 8, 2003
Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parametersLun-Gen Lu, Min-De Zeng, Mo-Bin Wan, et al.
World Journal of Gastroenterology|May 20, 2005
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis BPing Liu, Yi-Yang Hu, Cheng Liu, et al.
World Journal of Gastroenterology|December 12, 2003
Relationship between clinical and pathologic findings in patients with chronic liver diseasesLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 27, 2004
[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial]Lun-gen Lu, Min-de Zeng, Yi-min Mao, et al.
Hepatology International|July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patientsJi-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.
World Journal of Gastroenterology|October 16, 2004
Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical studyYi-Min Mao, Min-De Zeng, Lun-Gen Lu, et al.
World Journal of Gastroenterology|November 8, 2003
Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trialLun-Gen Lu, Min-De Zeng, Yi-Min Mao, et al.
Pageof 3